Amelioration of Auditory Response by DA9801 in Diabetic Mouse

Figure 3

Nr3c1 mRNA and protein expressions in liver. (a) Immunoblotting was performed on liver protein extracts using antibody of Nr3c1 and β-actin which was used as constitutive control for normalization. (b) mRNA levels of Nr3c1 in liver. (c) Relative protein expression levels of Nr3c1. Normal: nondiabetic mice model, DA100: nondiabetic mice model treated with DA9801 100 mg/kg, and DA300: nondiabetic mice model treated with DA9801 300 mg/kg. indicates significant differences from normal group using one-way ANOVA.

(a)

(b)

(c)